In label expansion bid, AbbVie and Roche's Venclexta falls short in multiple myeloma subset
29th September 2023 Uncategorised 0In label expansion bid, AbbVie and Roche’s Venclexta falls short in multiple myeloma subset zbecker Fri, 09/29/2023 – 10:53 More: In label expansion bid, AbbVie and Roche's Venclexta falls short in multiple myeloma subset Source: fierce
read more